These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32224137)

  • 21. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Campomizzi CS; Ghanatios GE; Estrada DF
    J Biol Chem; 2021 Nov; 297(5):101287. PubMed ID: 34634307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.
    Fielding AJ; Dornevil K; Ma L; Davis I; Liu A
    J Am Chem Soc; 2017 Dec; 139(48):17484-17499. PubMed ID: 29090577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
    McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
    J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.
    McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW
    Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes: Application to
    Ortega Ugalde S; Ma D; Cali JJ; Commandeur JNM
    SLAS Discov; 2019 Aug; 24(7):745-754. PubMed ID: 31208248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).
    Frederickson M; Selvam IR; Evangelopoulos D; McLean KJ; Katariya MM; Tunnicliffe RB; Campbell B; Kavanagh ME; Charoensutthivarakul S; Blankley RT; Levy CW; de Carvalho LPS; Leys D; Munro AW; Coyne AG; Abell C
    Eur J Med Chem; 2022 Feb; 230():114105. PubMed ID: 35065413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scalable Synthesis of Mycocyclosin.
    Zhu X; McAtee CC; Schindler CS
    Org Lett; 2018 May; 20(10):2862-2866. PubMed ID: 29701978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QM/MM study of the C-C coupling reaction mechanism of CYP121, an essential cytochrome p450 of Mycobacterium tuberculosis.
    Dumas VG; Defelipe LA; Petruk AA; Turjanski AG; Marti MA
    Proteins; 2014 Jun; 82(6):1004-21. PubMed ID: 24356896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Gray JL; Gilbert SH; Coyne AG; McLean KJ; Davis HJ; Munro AW; Abell C
    ChemMedChem; 2016 Sep; 11(17):1924-35. PubMed ID: 27432475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis--a potential target for antituberculosis drug design.
    Pulaganti M; Banaganapalli B; Mulakayala C; Chitta SK; C M A
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1407-32. PubMed ID: 24203275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis.
    Gl B; Rajput R; Gupta M; Dahiya P; Thakur JK; Bhatnagar R; Grover A
    Biochem J; 2020 Nov; 477(21):4167-4190. PubMed ID: 33030198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of l-asparaginase as a potential metabolic target against Mycobacterium tuberculosis.
    Kataria A; Singh J; Kundu B
    J Cell Biochem; 2019 Jan; 120(1):143-154. PubMed ID: 30230585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450.
    Bukhdruker S; Varaksa T; Grabovec I; Marin E; Shabunya P; Kadukova M; Grudinin S; Kavaleuski A; Gusach A; Gilep A; Borshchevskiy V; Strushkevich N
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
    Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
    Child SA; Ghith A; Bruning JB; Bell SG
    J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.